Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Epelbaum

Showing results (41-50 of 65) with videos related to

Pageof 7
Sort By:
Radiology|May 1, 1990
Ga-67 SPECT before and after treatment of lymphomaD Front, O Israel, R Epelbaum, et al.
Pathology Oncology Research : POR|January 15, 1999
Haptoglobin-related protein as a serum marker in malignant lymphomaR Epelbaum, C Shalitin, R Segal, et al.
Radiology|February 1, 1992
Lymphoma: predictive value of Ga-67 scintigraphy after treatmentD Front, S Ben-Haim, O Israel, et al.
Clinical Nuclear Medicine|May 1, 1990
Normal and abnormal Ga-67 SPECT anatomy in patients with lymphomaO Israel, J Jerushalmi, S Ben-Haim, et al.
Journal of Surgical Oncology|February 1, 1988
Carcinoma of the nasopharynx in Northern Israel: epidemiology and treatment resultsM Stein, A Kuten, M Arbel, et al.
Harefuah|April 17, 2001
[The chemotherapeutic treatment of advanced Hodgkin's disease]R Epelbaum, N Haim, M Ben-Shahar, et al.
Radiology|April 20, 1999
Hodgkin disease: prediction of outcome with 67Ga scintigraphy after one cycle of chemotherapyD Front, R Bar-Shalom, M Mor, et al.
Cancer|May 15, 1991
In vivo measurements of the fraction of dose of bleomycin labeled with cobalt 57 delivered to human tumorsD Front, E Even-Sapir, O Israel, et al.
Radiology|January 22, 2000
Aggressive non-Hodgkin lymphoma: early prediction of outcome with 67Ga scintigraphyD Front, R Bar-Shalom, M Mor, et al.
British Journal of Cancer|August 1, 1994
Docetaxel (Taxotere) is active in non-small-cell lung cancer: a phase II trial of the EORTC Early Clinical Trials Group (ECTG)T Cerny, S Kaplan, N Pavlidis, et al.
Pageof 7

Showing results (41-50 of 65) with videos related to

Sort By:
Pageof 7
Radiology|May 1, 1990
Ga-67 SPECT before and after treatment of lymphomaD Front, O Israel, R Epelbaum, et al.
Pathology Oncology Research : POR|January 15, 1999
Haptoglobin-related protein as a serum marker in malignant lymphomaR Epelbaum, C Shalitin, R Segal, et al.
Radiology|February 1, 1992
Lymphoma: predictive value of Ga-67 scintigraphy after treatmentD Front, S Ben-Haim, O Israel, et al.
Clinical Nuclear Medicine|May 1, 1990
Normal and abnormal Ga-67 SPECT anatomy in patients with lymphomaO Israel, J Jerushalmi, S Ben-Haim, et al.
Journal of Surgical Oncology|February 1, 1988
Carcinoma of the nasopharynx in Northern Israel: epidemiology and treatment resultsM Stein, A Kuten, M Arbel, et al.
Harefuah|April 17, 2001
[The chemotherapeutic treatment of advanced Hodgkin's disease]R Epelbaum, N Haim, M Ben-Shahar, et al.
Radiology|April 20, 1999
Hodgkin disease: prediction of outcome with 67Ga scintigraphy after one cycle of chemotherapyD Front, R Bar-Shalom, M Mor, et al.
Cancer|May 15, 1991
In vivo measurements of the fraction of dose of bleomycin labeled with cobalt 57 delivered to human tumorsD Front, E Even-Sapir, O Israel, et al.
Radiology|January 22, 2000
Aggressive non-Hodgkin lymphoma: early prediction of outcome with 67Ga scintigraphyD Front, R Bar-Shalom, M Mor, et al.
British Journal of Cancer|August 1, 1994
Docetaxel (Taxotere) is active in non-small-cell lung cancer: a phase II trial of the EORTC Early Clinical Trials Group (ECTG)T Cerny, S Kaplan, N Pavlidis, et al.
Pageof 7